RESULTS FROM A PHASE I/II TRIAL OF TINOSTAMUSTINE MONOTHERAPY IN ADVANCED SOLID TUMOURS (NCT03345485): SAFETY AND EFFICACY IN A SUBSET OF PATIENTS WITH ADVANCED OVARIAN CANCER (OVCA)

被引：0

作者：

Tinker, Anna V. ^{[1
]}

Chugh, Rashmi ^{[2
]}

Curigliano, Giuseppe ^{[3
]}

Kummar, Shivaani ^{[4
]}

Schneider, Reva ^{[5
]}

Strauss, James ^{[5
]}

Janik, Tomas ^{[6
]}

Manamley, Nick ^{[6
]}

Hilgier, Kasia ^{[6
]}

Oaknin, Ana ^{[7
]}

机构：

[1] BC Canc, Vancouver, BC, Canada

[2] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA

[3] European Inst Oncol, IRCCS, Milan, Italy

[4] Oregon Hlth & Sci Univ, Portland, OR USA

[5] Mary Crowley Canc Res, Dallas, TX USA

[6] Mundipharma Res Ltd, Cambridge, England

[7] Hosp Univ Vall Hebron, Gynaecol Canc Programme, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain

来源：

关键词：

D O I：

10.1136/ijgc-2023-ESGO.526

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

163

引用

页码：A252 / A252

页数：1